Showing results (1451-1460 of 1,621) with videos related to
Sort By:
Pageof 163
Diabetologia|May 13, 2011
Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signallingR M Holmes, Z Yi, E De Filippis, et al.Arthritis and Rheumatism|July 1, 2009
Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagenMarkella Ponticos, Alan M Holmes, Xu Shi-wen, et al.The EMBO Journal|December 20, 2003
Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteinsNael Nadif Kasri, Anthony M Holmes, Geert Bultynck, et al.Medical Physics|July 2, 2021
Report of AAPM Task Group 219 on independent calculation-based dose/MU verification for IMRTTimothy C Zhu, Sotiris Stathakis, Jennifer R Clark, et al.Ophthalmology|November 13, 2007
Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years, Michael X Repka, Danielle L Chandler, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|August 13, 2008
A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years, Michael X Repka, Raymond T Kraker, et al.Molecular Genetics and Metabolism|December 3, 2023
Best practice recommendations for the management of anxiety during the pegvaliase journeyKendra J Bjoraker, Caroline Eggerding, Elisheva Ellenberg, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2017
Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experienceBeatrice J Edwards, Ming Sun, Xiaotao Zhang, et al.STAR Protocols|August 11, 2024
Protocol for fluorescent live-cell staining of tardigradesClayton J Harry, Jonathan D Hibshman, Amor Damatac, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|May 16, 2007
Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 yearsRichard W Hertle, Mitchell M Scheiman, Roy W Beck, et al.Pageof 163